- Prior Authorization: Parkinson's Disease:
Documented Diagnosis: Yes
Duration: 1 plan year
Reauthorization Required: Yes
- Step Therapy: Parkinson's Disease:
ST Single Generic
- Parkinson's Disease:
Duration: 1 plan year
Documented Diagnosis: Yes
Medical Test Required: No
Reauthorization Required: Yes
Duration of Reauthorization: = 1 plan year
Diagnosis Type(s): Unspecified
Clinically documented acute, intermittent treatment of hypomobility "off" episodes: No
Concomitant Use of Max Tolerable Dose of levodopa + 1 selegiline,pramipexole,entacapone,rasagiline: No
Use as adjunct therapy: No
Requires concomitant anti-emetic agent: No
Supporting Documentation Requirements: 1 of Chart Notes;Lab Tests
|